The case against Purdue and other manufacturers was scheduled to go to trial in May. Accusations against the Stamford, Connecticut-based company included downplaying the addiction risk of opioids while overstating the benefits.
OxyContin maker Purdue Pharma and its owners, the Sackler family, have agreed to pay $270 million to the state of Oklahoma to settle a lawsuit accusing the drugmaker of ruthlessly marketing and misleading the public about the dangers of its highly addictive narcotic.The company previously denied any wrongdoing, saying labels for its painkiller carried warnings about the risk of abuse and misuse associated with the drugs.
As a part of the agreement, unveiled Tuesday, Purdue will contribute $102.5 million to fund the creation of a National Center for Addiction Studies at Oklahoma State University. The company will also donate $20 million worth of medicines to support the Center's treatment mission. "Purdue is very pleased to have reached an agreement with Oklahoma that will help those who are battling addiction now and in the future," Purdue Pharma CEO Craig Landau, said in a statement."We applaud Attorney General Mike Hunter for his leadership in making such an agreement possible."
OxyContin is a prescription drug used to treat moderate to severe pain in adults. From 1999 to 2017, nearly 218,000 people have died in the United States from overdoses related to prescription opioids, according to the U.S. Centers for Disease Control and Prevention. OxyContin first came on the market in 1996.
Earlier this month, Purdue's chief executive Landau said the company was considering bankruptcy to protect its assets against thousands of lawsuits for its alleged role in the opioid epidemic. Purdue was founded in the 1950s by brothers Arthur, Mortimer and Raymond Sackler.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Purdue Pharma agrees to $270 million settlement in Oklahoma opioid casePurdue Pharma agrees to $270 million settlement in Oklahoma opioid case via ReutersTV
Read more »
Former DEA official now working for Oxycontin maker Purdue PharmaEXCLUSIVE: A former senior DEA official who testified before Congress on the government's efforts to stop the opioid epidemic is now working for Oxycontin maker Purdue Pharma
Read more »
OxyContin maker Purdue Pharma reaches $270 million settlement related to opioid crisisOxyContin maker Purdue Pharma reaches $270 million settlement related to opioid crisis, with $200 million earmarked for an opioid center at Oklahoma State University.
Read more »
OxyContin-maker Purdue Pharma reaches opioid settlement with Oklahoma Attorney General: SourceOxyContin-maker Purdue Pharma has agreed to settle a lawsuit by the state of Oklahoma accusing it of helping igniting the nationwide opioid crisis, a person familiar with the matter confirmed to CNBC.
Read more »
OxyContin-maker Purdue Pharma reaches opioid settlement with Oklahoma, sources sayPurdue Pharma agreed to settle the state of Oklahoma’s claims its illegal marketing of the Oxycontin painkiller caused financial devastation to local communities, the first accord in a recent wave of lawsuits stemming from the U.S. opioid crisis, according to people familiar with the matter.
Read more »
OxyContin maker Purdue Pharma agrees to settle with Oklahoma: sourceNEW: Purdue Pharma has settled with Oklahoma AG for $270M, marking the first significant settlement for a company that faces more than 1,600 cases related to the opioid crisis, according to a person familiar with the matter.
Read more »
Sackler Family Actively Trying to Resolve Purdue Pharma LawsuitsMembers of the Sackler family who own OxyContin maker Purdue Pharmahave become more involved in settlement talks to resolve the company’s share of lawsuits accusing drug makers of helping spark the opioid crisis.
Read more »
OxyContin maker Purdue reaches $270 million settlement in Oklahoma opioid case: sourcePurdue Pharma LP and members of the wealthy Sackler family that own the OxyConti...
Read more »
OxyContin maker Purdue agrees to settle Oklahoma opioid case: sourcePurdue Pharma LP has agreed to settle a lawsuit by the state of Oklahoma accusin...
Read more »